S E Molchan - JoVE Visualize

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Journal of Psychiatric Research|July 1, 1992

Distribution of peripheral lymphocytes in Alzheimer patients and controlsM W Dysken, M D Minichiello, J L Hill, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1994

A double FDG/PET study of the effects of scopolamine in older adultsS E Molchan, J A Matochik, A J Zametkin, et al.

Psychopharmacology|September 1, 1995

Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT studyT Sunderland, G Esposito, S E Molchan, et al.

Biological Psychiatry|February 1, 1991

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersB A Lawlor, P A Newhouse, T J Balkin, et al.

Psychopharmacology|January 1, 1990

TRH attenuates scopolamine-induced memory impairment in humansS E Molchan, A M Mellow, B A Lawlor, et al.

Biological Psychiatry|June 1, 1991

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depressionS E Molchan, B A Lawlor, J L Hill, et al.

Biological Psychiatry|October 1, 1993

Autonomic dysfunction in patients with dementia of the Alzheimer typeB Vitiello, R C Veith, S E Molchan, et al.

Psychiatry Research|July 1, 1989

Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjectsB A Lawlor, T Sunderland, J L Hill, et al.

Biological Psychiatry|July 1, 1991

Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's diseaseT Sunderland, W H Berrettini, S E Molchan, et al.

Psychoneuroendocrinology|January 1, 1993

CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measuresS E Molchan, J L Hill, R A Martinez, et al.

Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Journal of Psychiatric Research|July 1, 1992

Distribution of peripheral lymphocytes in Alzheimer patients and controlsM W Dysken, M D Minichiello, J L Hill, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1994

A double FDG/PET study of the effects of scopolamine in older adultsS E Molchan, J A Matochik, A J Zametkin, et al.

Psychopharmacology|September 1, 1995

Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT studyT Sunderland, G Esposito, S E Molchan, et al.

Biological Psychiatry|February 1, 1991

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersB A Lawlor, P A Newhouse, T J Balkin, et al.

Psychopharmacology|January 1, 1990

TRH attenuates scopolamine-induced memory impairment in humansS E Molchan, A M Mellow, B A Lawlor, et al.

Biological Psychiatry|June 1, 1991

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depressionS E Molchan, B A Lawlor, J L Hill, et al.

Biological Psychiatry|October 1, 1993

Autonomic dysfunction in patients with dementia of the Alzheimer typeB Vitiello, R C Veith, S E Molchan, et al.

Psychiatry Research|July 1, 1989

Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjectsB A Lawlor, T Sunderland, J L Hill, et al.

Biological Psychiatry|July 1, 1991

Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's diseaseT Sunderland, W H Berrettini, S E Molchan, et al.

Psychoneuroendocrinology|January 1, 1993

CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measuresS E Molchan, J L Hill, R A Martinez, et al.

Pageof 3